MT Newswires6d agobullish
RBC Raises Price Target on AbbVie to $330 From $280, Keeps Outperform RatingNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investing.com87d agobullish
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation